Amphastar Pharmaceuticals Inc

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
03209R103
SEDOL
BNFWZS4
CIK
0001297184
www.amphastar.com
LEI: 54930055TH0ZLSAQMJ38
©
New: Infographics X-Lab
FIGI: BBG000BW90S6
AMPH
Amphastar Pharmaceuticals Inc
GICS: 35202010 · Sektor: Healthcare · Sub-Sektor: Drug Manufacturers—Specialty & Generic
AI
PROFILER
NAME
Amphastar Pharmaceuticals Inc
ISIN
US03209R1032
TICKER
AMPH
MIC
XNAS
REUTERS
AMPH.OQ
BLOOMBERG
AMPH US
F&G: 59
6.405,11 S&P · 16,78 Vola-Index · 117.096,81 BTC · 1,16419 EURUSD
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
TradingView ActivTrader MT4 MT5
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von ACCESS Newswire bereitgestellt.
Do., 07.08.2025       Amphastar Pharmaceuticals
US03209R1032

- Reports Net Revenues of $174.4 million for the Three Months Ended June 30, 2025- GAAP net income of $31.0 million, or $0.64 per share, for the second quarter- Adjusted non-GAAP net income of $40.9 million, or $0.85 per share, for the second quarter- Company to hold a conference call today at 2:00 p.m. Pacific Time RANCHO CUCAMONGA, CA / ACCESS Ne...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Di., 29.07.2025       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESS Newswire / July 29, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2025 ended June 30, 2025, after the market closes on Thursday, August 7, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To ...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Mo., 14.07.2025       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESS Newswire / July 14, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), a bio-pharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, has announced a multi-year expansion of its U.S. manufacturing operations at its hea...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Do., 22.05.2025       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 22, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, EVP of Corporate Administration, will be participating in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5th, 2025, at 2:00 pm ET. For ...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Fr., 09.05.2025       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 9, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating in an Analyst-Moderated fireside chat at the 2025 Bank of America Health Care Conference on Wednesday, May 14th, 2025, at 1:40 pm PT. For acces...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Mi., 07.05.2025       Amphastar Pharmaceuticals
US03209R1032

Reports Net Revenues of $170.5 Million for the Three Months Ended March 31, 2025 RANCHO CUCAMONGA, CA / ACCESS Newswire / May 7, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2025.First Quarter HighlightsNet revenues of $170.5 milli...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Mi., 30.04.2025       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2025 ended March 31, 2025, after the market closes on Wednesday, May 7th, 2025, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.To...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Do., 03.04.2025       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 3, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be participating in an Analyst-Moderated fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9th, 2025, at 1:30 pm ET. ...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Fr., 28.03.2025       Amphastar Pharmaceuticals
US03209R1032

Recognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that International Medication Systems, Ltd. ("IMS"), a subsidiary of Amphastar Pharmaceuticals, Inc. ("Amphastar") r...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
Mi., 05.03.2025       Amphastar Pharmaceuticals
US03209R1032

RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations will be presenting at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12th, 2025, at 10:30 am ET. For access, visit A...
Read More
Amphastar Pharmaceuticals
Technical Analysis Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S